NCT03411746View on ClinicalTrials.gov

Evaluation of the Level and Prognostic Relevance of New Neuroinflammation Markers in Subarachnoid Haemorrhage

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

January 30, 2019

Study Completion Date

July 31, 2019

Conditions
Subarachnoid Hemorrhage
Interventions
OTHER

Subarachnoid haemorrhage

Data on the type of patients enrolled have been described already in other sections.

Trial Locations (1)

28100

Rosanna Vaschetto, Novara

All Listed Sponsors
lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

NCT03411746 - Evaluation of the Level and Prognostic Relevance of New Neuroinflammation Markers in Subarachnoid Haemorrhage | Biotech Hunter | Biotech Hunter